CASP3 and early-onset autosomal dominant Alzheimer disease: It was found that miR-155 inhibitors could restore cognitive performance in rat models of Alzheimer's disease by mitigating the upregulation of apoptotic Caspase-3 in the hippocampus [40] as well as experimental traumatic brain injury in mice [41].